Distal tip for bone fixation devices

Information

  • Patent Grant
  • 9687281
  • Patent Number
    9,687,281
  • Date Filed
    Tuesday, March 12, 2013
    11 years ago
  • Date Issued
    Tuesday, June 27, 2017
    6 years ago
Abstract
Distal tip designs for bone fixation devices are disclosed. In some embodiments, a system for bone fixation includes a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member; a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light-sensitive liquid; wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.
Description
FIELD

The embodiments disclosed herein relate to distal tip for systems for use during an bone fixation procedure and methods of their use.


BACKGROUND

Fracture repair is the process of rejoining and realigning the ends of broken bones. Currently there are several internal approaches to repair, strengthen and support a fractured bone. Conventional internal fixation devices include wires, plates, rods, pins, nails, and screws to support the fractured bone directly, as well as the addition of reinforcing materials to the fractured bone. Newer internal fixation devices include expandable members that can be expanded with curable material and hardened inside the intramedullary cavity of a bone to provide a conformal fit inside the intramedullary cavity, which leads to greater support and strength to the healing bone. However, there is still a need for further improvements of such internal fixation devices.


SUMMARY

Distal tip designs for bone fixation devices are disclosed. According to some aspects illustrated herein, there is provided a device for bone fixation that includes a delivery catheter comprising an outer tube and an inner tube disposed within the outer tube and extending beyond the outer tube; an expandable member having a proximal region and a distal region, the expandable member being releasably attached about a distal end of the delivery catheter at the proximal region of the expandable member, and a distal cap attached to the distal region of the expandable member to seal the expandable member; and an inner compartment in the distal region of the expandable member, the inner tube and enable movement of the inner tube within the inner compartment.


According to some aspects illustrated herein, there is provided a system for bone fixation that includes a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member; a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light-sensitive liquid; wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.


According to some aspects illustrated herein, there is provided a method for bone fixation that includes advancing to a fractured bone a device comprising a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is attached about the distal end of the delivery catheter at the proximal region of the expandable member; and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.





BRIEF DESCRIPTION OF THE DRAWINGS

The presently disclosed embodiments will be further explained with reference to the attached drawings, wherein like structures are referred to by like numerals throughout the several views. The drawings shown are not necessarily to scale, with emphasis instead generally being placed upon illustrating the principles of the presently disclosed embodiments.



FIG. 1 is a prospective view of an embodiment of a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 2 is a close-up view of an embodiment of a distal end of a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 3 illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 4 illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 5 illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 6 illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 7A illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 7B illustrates an embodiment of a distal tip design for a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 8 shows a close up view of an embodiment of a proximal end of a device for repairing a weakened or fractured bone of the present disclosure.



FIG. 9A, FIG. 9B, FIG. 9C, FIG. 9D and FIG. 9E illustrate an embodiment method for repairing a weakened or fractured bone of the present disclosure.





While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.


DETAILED DESCRIPTION

Systems and methods for bone fixation procedures are disclosed herein. In some embodiments, distal tip designs for internal bone fixation devices are disclosed.



FIG. 1 illustrates the main components of an embodiment of a device for repairing a weakened or fractured bone. The device 100 includes a delivery catheter 101 having an elongated shaft with a proximal end 112, a distal end 114, and a longitudinal axis therebetween. In an embodiment, the delivery catheter 101 has a diameter of about 3 mm. The distal end 104 of the delivery catheter 101 terminates in an expandable member 200 (also referred to herein as a conformable member or a balloon portion). The expandable member 200 may move from a deflated state to an inflated state when at least one reinforcing material is delivered to the expandable member 200. In some embodiments, the expandable member 200 may be releasably attached to the delivery catheter 101. In some embodiments, the expandable member 200 may be placed inside an intramedullary cavity of a bone for internal bone fixation.



FIG. 2 is a side view of an embodiment of a distal end 114 of the flexible delivery catheter 101. The distal end 114 includes the expandable member 200 releasably mounted on the flexible delivery catheter 101. The expandable member 200 has a wall 202 with an outer surface 205 and an inner surface 230. The inner surface 230 defines an inner cavity 235. In some embodiments, the delivery catheter 101 may include multiple inner lumens or voids. For example, as shown in FIG. 2, the delivery catheter 101 may include an outer tube 209 and a central tube 220 concentrically disposed within the delivery catheter 101. An inner void 210 may be formed between the outer tube 209 and the central tube 220. The inner void 210 may be utilized for passing a light-sensitive liquid into the inner cavity 235 of the expandable member 200. In some embodiments, the central tube 220 includes an inner lumen 211 for passing a light-conducting fiber (which is not illustrated in FIG. 2) into the expandable member 200 to cure the light sensitive liquid inside the inner cavity 235 of the expandable member, as described in detail below. It should be noted that while the delivery catheter 101 is described as having the central lumen 220 concentric with the outer tube 209, the central lumen 220 may be off-set relative to the outer tube 209.


In some embodiments, the expandable member 200 is manufactured from a thin-walled, non-compliant (non-stretch/non-expansion) conformable material. The expandable member 200 may be formed of a pliable, resilient, conformable, and strong material, including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In some embodiments, the expandable member 200 of the present disclosure is constructed out of a PET nylon aramid or other non-consumable materials. The expandable member 200 may be impregnated with a radiopaque material to enhance the visibility of the expandable member 200. The expandable member 200 is biocompatible, thus preventing or reducing possible adverse reactions after insertion into a fractured bone. In some embodiments, the expandable member 200 is made from a material that is non-toxic, non-antigenic and non-immunogenic.


The expandable member 200 includes a proximal area 212 and a distal area 214. The proximal area 212 of the expandable member 200 is releasably connected to the delivery catheter 101. The distal area 214 may be connected to the delivery catheter 101 in a variety of ways.


In reference to FIG. 3, in some embodiments, the distal area 214 of the expandable member 200 may be connected to a distal cap 300, which may be disposed at the distal end of the central tube 220. The distal cap 300 terminates and seals off the area 214 of the expandable member 200 to prevent the flow of a light-sensitive liquid outside the balloon and the ingress of bodily fluids inside the balloon. One potential benefit of utilizing the distal cap 300 is ease of manufacture and more consistent tip quality when compared to traditional melt forming of expandable member 200 directly to the delivery catheter. An additional benefit of the use of the distal cap 300 may also include the ability to reflect back or scatter light radiating from the end of the conducting fiber to improve the light-sensitive liquid cure times or depth of cure. The reflected light from the distal cap 300 may increase the energy that is directed towards the light-sensitive liquid in the expandable member 200 and thus may increase the photo-initiation rate (and thus polymerization rate) of the light-sensitive liquid.


In some embodiments, the distal cap 300 may be formed, molded or machined from an implant grade polymer (e.g., PET), or another biocompatible material. The distal cap 300 may also be made from a filled material. For example, the PET polymer may be blended with a radiopaque material (e.g., barium sulfate, tungsten, tantalum, etc.) such that the distal cap 300 may be viewed with the assistance of fluoroscopic imaging. In some embodiments, the distal cap 300 may also be covered with a reflective material such as a gold film (or other metallic highly polished implant grade film) to enable the distal cap 300 to reflect light radiating from the end of the light pipe back into the balloon. This reflected light can help to reduce the cure time of the light sensitive liquid contained within the expandable member 200 to due to the increase in light energy directed at the light sensitive liquid. In some embodiments, the distal cap 300 may also be fabricated from a crystalline material (such as crystalline PET) to block the transmission of light through the end of the device 100 and to reflect and/or scatter the light back to the light sensitive liquid in the expandable member 200.


As illustrated in FIG. 3, a distal cap 300 includes a body 302 having a proximal end 304 and a distal end 306. The body 302 defines an inner compartment 303 for receiving the central tube 220 therein. In some embodiments, the inner compartment 303 is tubular to accommodate the central tube 220 therein. The proximal end 304 of the body 302 is open to allow the central tube 220 to be inserted into the inner compartment 303. The distal cap 300 may stabilize the central tube 220 and may minimize snaking or bowing of the central tube 220 during the operation. In some embodiments, the central tube 300 may be free floating within the distal cap 300, that is, the distal end of the central tube 220 is capable of movement within the inner compartment 303. In some embodiments, being free floating within the inner compartment 303, the central tube 220 can move within the inner compartment 303 in a radial direction, a longitudinal direction or both a radial direction and a longitudinal direction. Because in some embodiments the central tube 220 is free-floating, unrestrained or unbound within the inner compartment 303, the central tube 220 can automatically adjust to the pressure maintained within the expandable member 200 to minimize or even eliminate the deformation of the central tube along its length. For example, as the expandable member 200 expands and contracts in diameter and length during infusion or withdrawal of the light sensitive liquid, the central tube 220 can adjust in length thereby reducing the stress on the central tube 220 and the light conducting fiber inside the central tube 220. In some embodiments, where the central tube 220 is free floating within the distal cap 300, the pleating and wrapping of the expandable member 200 may be improved, which may prevent damage to the expandable member 200 during manufacturing (improved yields), decrease the likelihood of leak occurrence either during manufacturing or in use, and potentially result in improvement on profile (able to wrap down to a smaller diameter) and insertion force (due to reduced friction).


While the central tube 220 may be free floating, in some embodiments, the central tube 220 may also be tethered to the distal cap by means of a filament or fiber to prevent the central tube 220 from becoming completely dislodged from within the distal cap 300. The filament or fiber may be elastic or rigid under tension and compression. In some embodiments, the central tube 220 may be rigidly secured to the distal cap 300. The central tube 220 may be secured inside the compartment 303 by press fitting the central tube 220 into the compartment 303; applying permanent adhesive on the surfaces between the central tube 220 and the compartment 303; melt bonding the two surfaces together or other techniques.


The distal end 306 of the body 302 may be either open or closed. In some embodiments, the distal cap 300 closes the distal tip 306 of the body 302 to close the distal tip 306. The distal cap 300 includes an inner surface 309, which faces the body 302, and an outer surface 310, which faces away from the body 302. In some embodiments, the outer surface 310 of the distal cap 300 may be rounded or smooth to provide the device 100 with an atraumatic distal point. In some embodiments, the distal cap 300 may have a semi-circular shape with a flat inner surface and a curved outer surface. In some embodiments, the body 302 may be open as long as there is a seal created, such as by for example, sealing the central tube 220 to the inner surface of the inner compartment 303 to prevent movement of fluids in and out of the expandable member 200.


In reference to FIG. 3, in some embodiments, the material forming the expandable member 200 may be attached to the outer surface of the body 302. In some embodiments, the outer surface of the body 302 includes recessed attachment sections 312a, 312b to which the material of the expandable member 200 can be attached. In some embodiments, the outer surface of the body 302 may be recessed by a depth approximately equal to the thickness of the expandable member material. In this manner, when the expandable member material is attached to the body 302, the outside of the expandable member material is substantially aligned with the outer surface 310 of the distal cap 300. The material of the expandable member 200 can be attached to the body 302 by a variety of methods, including, without limitation, adhesives such as cyano-acrylates or epoxies, crimping metallic rings over the expandable portion, melt bonding the expandable member to the body 302 with the use of heat (e.g., RF generated), ultrasonically welding the expandable member to the body 302, or another method or combination of methods.


In reference to FIG. 4, in some embodiments, the material of the expandable member 200 may be attached to the inner surface of the body 302 of the distal cap 300.


In reference to FIG. 5, in some embodiments, the body 302 may have a slotted wall, formed by a first wall or prong 314 and a second wall or prong 316 spaced apart from one another to form a slot 318 between the first wall 314 and the second wall 316. The material of the expandable member 200 can be inserted into the slot 318 and secured within the slot 318 between the first wall 314 and the second wall 316 by a variety of methods. This design may provide additional separation resistance between the two components which may translate to an increase in burst pressure and fatigue resistance at this interface.


In some embodiments, the central tube 220 may be sealed distally by a melt 221 formed by a process such as an RF heated mold (as shown in FIG. 3, FIG. 4 and FIG. 5). Alternatively, as shown in FIG. 6, the central tube 220 may be sealed with a tube plug 320 before being inserted into the distal cap 300. The tube plug 320 can be fabricated in a similar fashion to the distal cap 300 in terms of material and fillers (providing the same benefits described previously for the distal cap 300). Alternatively, the tip of the central tube 220 can be left not sealed, as long as there is a seal between the outer surface of the central tube 220 and the inner surface of the compartment 303 to prevent leaks into or out of the central tube 220.


In reference to FIG. 7A, in some embodiments, the body 302 of the distal cap 300 is formed by the walls of the expandable member 200. In reference to FIG. 7B, in some embodiments, the distal cap 300 may be melt formed from the distal end material of the expandable member 200, while the walls of the expandable member 200 may form the body 302 of the distal cap 300, defining the inner compartment 303. In some embodiments, the end cap may be formed from a separate heat shrink tube. The heat shrink tube may be placed inside the expandable member or external to the expandable member to permit melt forming and/or sealing of the end of the expandable member. In the embodiments shown in FIG. 7A and FIG. 7B, the central tube 220 may be either free floating or may be attached to the distal cap 300.


In reference to FIG. 8, a close-up view of an embodiment proximal end 112 of the delivery catheter 101 is illustrated. The proximal end 112 of the flexible delivery catheter 101 includes at least two ports. In the embodiment shown in FIG. 1, the proximal end 112 includes three ports 115, 125, and 135. Port 115 can accept, for example, a light-conducting fiber. In some embodiments, the light-conducting fiber is an optical fiber. In some embodiments, the optical fiber has an outer diameter from about 1 mm to about 3 mm. The optical fiber is sized to pass through an inner lumen of the delivery catheter 101. The optical fiber can be made from any material, such as glass, silicon, silica glass, quartz, sapphire, plastic, combinations of materials, or any other material, and may have any diameter. In some embodiments, the optical fiber is made from a polymethyl methacrylate (PMMA) core with a transparent polymer cladding, often a fluoropolymer such as polytetrafluoroethylene. It should be appreciated that the above-described characteristics and properties of the optical fibers are exemplary and not all embodiments of the present disclosure are intended to be limited in these respects. Port 125 can accept, for example, a syringe housing air or fluid. In some embodiments, port 125 can be used as an air vent during sterilization. Port 135 can accept, for example, a syringe housing a light-sensitive liquid. In some embodiments, the light-sensitive liquid is a liquid monomer. In some embodiments, the syringe maintains a low pressure during the infusion and aspiration of the light-sensitive liquid. In some embodiments, the syringe maintains a low pressure of about 10 atmospheres or less during the infusion and aspiration of the light-sensitive liquid. In some embodiments, the syringe maintains a pressure of between about 1 and about 3 atmospheres.


Light-sensitive liquid can be introduced into the proximal end 112 of the delivery catheter 101 and passes through the inner void 210 of the delivery catheter 101 up into the inner cavity 235 of the expandable member 200 to move the expandable member from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable member, in order to form a rigid orthopedic stabilizer. In some embodiments, the light-sensitive liquid is provided as a unit dose. As used herein, the term “unit dose” is intended to mean an effective amount of light sensitive liquid adequate for a single session. By way of example, a unit dose of a light sensitive liquid of the present disclosure for expanding an expandable member of the present disclosure may be defined as enough light-sensitive liquid to expand the expandable member so that the expanded expandable member realigns a fractured bone and/or secures the bone back into an anatomical position. The amount of realigning may vary somewhat from user to user. Thus, a user using a unit dose may have excess light-sensitive liquid left over. It is desirable to provide enough light-sensitive liquid that even the above-average user will have an effective amount of realignment. In some embodiments, a unit dose of a light-sensitive liquid of the present disclosure is contained within a container. In some embodiments, a unit dose of a light-sensitive liquid of the present disclosure is contained in an ampoule. In some embodiments, the expandable member is sufficiently shaped to fit within a space or a gap in a fractured bone. In some embodiments, the light-sensitive liquid can be delivered under low pressure via a standard syringe attached to the port 135. The light-sensitive liquid can be aspirated and reinfused as necessary, allowing for adjustments to the expandable member. These properties allow a user to achieve maximum fracture reduction prior to activating a light source and converting the liquid monomer into a hard polymer.


A light-conducting fiber communicating light from the light source can be introduced into the proximal end 112 of the delivery catheter 101 through port 115 and passes within an inner lumen of the delivery catheter 101 up into the expandable member. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 390 nm to 770 nm, the visible spectrum. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 410 nm to 500 nm. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 430 nm to 450 nm. The light-sensitive liquid remains a liquid monomer until activated by the light-conducting fiber (cures on demand). In some embodiments, the liquid monomer is exposed to an appropriate frequency of light and intensity to cure the monomer inside the expandable member and form a rigid structure. In some embodiments, the liquid monomer is exposed to electromagnetic spectrum that is visible (frequency that corresponds to a band in the vicinity of 390 nm to 770 nm). In some embodiments, the liquid monomer is radiolucent, which permit x-rays to pass through the liquid monomer. Radiant energy from the light source is absorbed and converted to chemical energy to quickly (e.g., cured in about five seconds to about 10 minutes) polymerize the monomer. This cure affixes the expandable member in an expanded shape. A cure may refer to any chemical, physical, and/or mechanical transformation that allows a composition to progress from a form (e.g., flowable form) that allows it to be delivered through the inner void in the delivery catheter 101, into a more permanent (e.g., cured) form for final use in vivo. For example, “curable” may refer to uncured composition, having the potential to be cured in vivo (as by catalysis or the application of a suitable energy source), as well as to a composition in the process of curing (e.g., a composition formed at the time of delivery by the concurrent mixing of a plurality of composition components).


Additives may be included in light-sensitive liquids, including, but not limited to, drugs (for example, antibiotics), proteins (for example, growth factors) or other natural or synthetic additives (for example, radiopaque or ultrasonically active materials). In some embodiments, the viscosity of the light-sensitive liquid has a viscosity of about 1000 cP or less. In some embodiments, the light-sensitive liquid has a viscosity ranging from about 650 cP to about 450 cP. The expandable member may be inflated, trial fit and adjusted as many times as a user wants with the light-sensitive liquid, up until the light source is activated, when the polymerization process is initiated. Because the light-sensitive liquid has a liquid consistency and is viscous, the light-sensitive liquid may be delivered using low pressure delivery and high pressure delivery is not required, but may be used.


In some embodiments, a contrast material may be added to the light-sensitive liquid without significantly increasing the viscosity. Contrast materials include, but are not limited to, bismouth subcarbonate, barium sulfate, bismuth subcarbonate, tantalum, or other contrast materials known in the art. The light-sensitive liquid can be introduced into the proximal end of the delivery catheter and passes within the inner void of the delivery catheter up into an inner cavity of the expandable member to change a thickness of the expandable member without changing a width or depth of the expandable member. In some embodiments, the light-sensitive liquid is delivered under low pressure via the syringe attached to the port. The light-sensitive liquid can be aspirated and reinfused as necessary, allowing for thickness adjustments to the expandable body prior to activating the light source and converting the liquid monomer into a hard polymer. Low viscosity allows filling of the intramedullary implant through a very small delivery system.


One or more radiopaque markers or bands may be placed at various locations along the expandable member 200 and/or the delivery catheter 101. A radiopaque ink bead may be placed at a distal end of the expandable member for alignment of the apparatus during fluoroscopy. The one or more radiopaque bands and radiopaque ink bead, using radiopaque materials such as bismouth subcarbonate, barium sulfate, tantalum, or other materials known to increase radiopacity, allows a medical professional to view the apparatus using fluoroscopy techniques. The one or more radiopaque bands also provide visibility during inflation of the expandable member to determine the precise positioning of the expandable member during placement and inflation.


In some embodiments, the expandable member 200 can have a length greater than about 300 mm and a diameter greater than about 20 mm. In such embodiments, there is the potential that during the curing of the light-sensitive liquid, a far distal area 214 of the expandable member 200 will exhibit a shrinkage upon cure of about 2 to about 3 percent, while a proximal area 212 of the expandable member 200 is being cured. In some embodiments, to prevent this from transpiring, the central tube 220 of the expandable member 200 can be pressurized by virtue of the infusion of either air or other fluids (saline, water) through port 125 at the proximal end 112 of the delivery catheter 101. The infusion will cause internal diameter pressure against the light-sensitive liquid contained within the inner cavity 235 of the expandable member 200 so that during the curing process, the pressure keeps the light-sensitive liquid pressurized, and up in contact with inner surface 230 of the expandable member 200. When the light-conducting fiber is inserted within the central tube 220 and the light-sensitive liquid is infused, the extra space is pressed down on the central tube 220. In some embodiments, the central tube 220 is rigid and heat resistant so it does not deform, collapse or expand, due to the light energy from the light conducting fiber to facilitate easy removal of the light conducting fiber after the cure cycle. In some embodiments, an expandable member of the present disclosure has a diameter ranging from about 4 mm to about 30 mm. In some embodiments, an expandable member of the present disclosure has a length ranging from about 20 mm to about 500 mm. An expandable member of the present disclosure may be round, flat, cylindrical, oval, rectangular or any desired shape for a given application. In some embodiments, an expandable member of the present disclosure has a diameter of about 4 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 5 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 50 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 7 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 7 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 4 mm to about 20 mm and a length of about 30 mm to about 280 mm.


In some embodiments, an outer surface of an expandable member of the present disclosure is resilient. In some embodiments, an outer surface of an expandable member of the present disclosure is substantially even and smooth. In some embodiments, an outer surface of an expandable member of the present disclosure is not entirely smooth and may have some small bumps or convexity/concavity along the length. In some embodiments, an outer surface of an expandable member of the present disclosure may have ribs, ridges, projections, bumps or other shapes. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member improve penetration of the at least one fastener into the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member improve penetration of the at least one fastener into the expandable member anywhere along a length of the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member increase friction between the outer surface of the expandable member and the at least one fastener so as to reduce slippage of the at least one fastener as the at least one fastener is driven towards the outer surface of the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member interacts with a threaded portion of the at least one fastener so as to improve penetration and fastening of the at least one fastener into the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member interact with a tip of the at least one fastener to improve the wedge ability of the tip of the fastener so as to decrease the driving force needed to penetrate the expandable member. In some embodiments, an outer surface of an expandable member of the present disclosure has an uneven geometry. In some embodiments, an outer surface of an expandable member of the present disclosure has a textured surface which provides one or more ridges that allow grabbing. In some embodiments, the one or more ridges on the textured surface of the expandable member allow grabbing of the at least one fastener so as to improve the penetration of the at least one fastener into the expandable member. In some embodiments, the one or more ridges on the textured surface of the expandable member allow grabbing of bone so as to improve adhesion between the expandable member and bone as regenerating bone grows onto the outer surface of the expandable member. In some embodiments, abrasively treating an outer surface of an expandable member of the present disclosure for example via chemical etching or air propelled abrasive media improves the connection and adhesion between the outer surface of the expandable member and a bone. The surfacing may significantly increase the amount of surface area that comes in contact with the bone resulting in a stronger grip. In some embodiments, the textured surface promotes bone growth onto the expandable member. In some embodiments, the textured surface promotes bone growth of regenerating bone onto the outer surface of the expandable member by grabbing the regenerating bone as it grows. In some embodiments, an expandable member of the present disclosure is made by extruding material into a tube shape, and then forming the tube into a balloon. When forming the tube into the balloon, the balloon can be, for example, pre-stamped or milled to include a desired design, desired shape or surface modification. Then, the tube is heated and radially expanded via compressed air for a specific amount of time. The formed balloon is cooled and includes the desired design, desired shape or surface modification.


In some embodiments, an expandable member of the present disclosure has an outer surface that is coated with materials such as drugs, bone glue, proteins, growth factors, or other coatings. For example, after a minimally invasive surgical procedure an infection may develop in a patient, requiring the patient to undergo antibiotic treatment. An antibiotic drug may be added to an outer surface of an expandable member of the present disclosure to prevent or combat a possible infection. Proteins, such as, for example, bone morphogenic protein or other growth factors have been shown to induce the formation of cartilage and bone. In some embodiments, a growth factor is added to an outer surface of an expandable member of the present disclosure to help induce the formation of new bone. In some embodiments, as the formation of new bone is induced the new bone interacts with a textured outer surface of the expandable member so that new bone is formed onto the textured outer surface of the expandable member. Due to the lack of thermal egress of light-sensitive liquid in an expandable member of the present disclosure, the effectiveness and stability of the coating is maintained.


In some embodiments, a stiffness of any of the expandable member of the present disclosure can be increased due to the presence of external stiffening members or internal stiffening members. In some embodiments, a wrapping, sheathing or an attachment of Nitinol or other metallic memory-type metal piece(s) are aligned in a longitudinal fashion, with multiple rods being placed circumferentially around the expandable member so as to have these metallic pieces change their configuration under a temperature change. In some embodiments, an inner surface of the metallic pieces (those surfaces that are in contact with the external circumferential surface of the intramedullary implant) are polished to increase internal reflection of the light from the light-conducting fiber. The metallic pieces are designed to be load-bearing shapes. In some embodiments, the metallic pieces have a low profile and can handle large loads. In some embodiments, metallic pieces may be positioned on the external circumferential surface of an expandable member. The metallic pieces can be aligned in a longitudinal fashion, circumferentially around the expandable member and can be interconnected with one another via connecting means such as wires. The wires will help hold the longitudinal metallic pieces in position. In some embodiments, the metallic pieces expand to increase the strength of the hardened expandable member. In some embodiments, the metallic pieces contract to increase the strength of the hardened expandable member. In some embodiments, metallic pieces are positioned on an internal circumferential surface of an expandable member. In some embodiments, two metallic memory-type metal wires, such as Nitinol, are positioned within an expandable member. Heat from a light-conducting fiber makes the metal wires get smaller, tensioning the hardened expandable member. In some embodiments, heat from a light-conducting fiber and reaction with the polymerization process, makes the metal wires get smaller, tensioning the hardened expandable member. In some embodiments, an expandable member is wrapped with a plurality of flat metallic plates that move into a corrugated or other shape upon a temperature change to increase the strength of the previously flat metal plate into a shape capable of handling a load. In some embodiments, the metals are rectangular, semicircular, hexagonal, or triangular in section, although not all embodiments are limited to these shapes.


An expandable member typically does not have any valves. One benefit of having no valves is that the expandable member may be inflated or deflated as much as necessary to assist in the fracture reduction and placement. Another benefit of the expandable member having no valves is the efficacy and safety of the implant. Since there is no communication passage of light-sensitive liquid to the body there cannot be any leakage of liquid because all the liquid is contained within the expandable member. In some embodiments, a permanent seal is created between the expandable member that is both hardened and affixed prior to the delivery catheter 101 being removed. The expandable member may have valves, as all of the embodiments are not intended to be limited in this manner.


In some embodiments, an expandable member of the present disclosure includes a pathway sufficiently designed for passing a cooling medium. Once the expandable member is expanded, a cooling media may be delivered within (via an internal lumen) or around (via external tubing) the expandable member in order to prevent the possibility of overheating. Medium used for cooling includes, but is not limited to, gases, liquids and combinations thereof. Examples of gases include, but are not limited to, inert gases and air. Examples of liquids include, but are not limited to, water, saline, saline-ice mixtures, liquid cryogen. In some embodiments, the cooling media is water. The cooling media can be delivered to the expandable member at room temperature or at a cooled temperature. In some embodiments, the cooling media improves the numerical aperture between that of the light-conducting fiber and the inner lumen for the light-conducting fiber because any air existing between the light-conducting fiber and the material of the expandable member is taken away so as to improve light transmission. Therefore, light will be transmitted from the light-conducting fiber to the light-sensitive liquid through the cooling medium as opposed to through air. In some embodiments, the cooling media transmitted through the inner lumen of the expandable member takes away extraneous heat. In some embodiments, no cooling media is used.


In some embodiments, a light-conducting fiber can be introduced into the inner lumen of the expandable member and activated to cure the light-sensitive liquid, while a cooling medium may flow through the inner lumen and out the distal end of the expandable member.


In reference to FIG. 9A, FIG. 9B, FIG. 9C, FIG. 9D and FIG. 9E, embodiment methods for implanting an intramedullary implant of the present disclosure within the intramedullary space of a weakened or fractured bone are illustrated. A minimally invasive incision (not shown) may be made through the skin of the patient's body to expose a fractured bone 902. The incision may be made at the proximal end or the distal end of the fractured bone 902 to expose the bone surface. Once the bone 902 is exposed, it may be necessary to retract some muscles and tissues that may be in view of the bone 902. As shown in FIG. 9A, an access hole 910 may be formed in the bone by drilling or other methods known in the art. In some embodiments, the access hole 910 has a diameter of about 4 mm to about 7 mm. In some embodiments, the access hole 910 has a diameter of about 9 mm.


The access hole 910 extends through a hard compact (cortical) outer layer 920 of the bone into the relatively porous inner or cancellous tissue 925. For bones with marrow, the medullary material should be cleared from the medullary cavity prior to insertion of the inventive device. Marrow is found mainly in the flat bones such as hip bone, breast bone, skull, ribs, vertebrae and shoulder blades, and in the cancellous material at the proximal ends of the long bones like the femur and humerus. Once the medullary cavity is reached, the medullary material including air, blood, fluids, fat, marrow, tissue and bone debris should be cleared or loosened to form a void. The void is defined as a hollowed out space, wherein a first position defines the most distal edge of the void with relation to the penetration point on the bone, and a second position defines the most proximal edge of the void with relation to the penetration site on the bone. The bone may be hollowed out sufficiently to have the medullary material of the medullary cavity up to the cortical bone removed. There are many methods for removing the medullary material that are known in the art and within the spirit and scope on the presently disclosed embodiments. Methods include those described in U.S. Pat. No. 4,294,251 entitled “Method of Suction Lavage,” U.S. Pat. No. 5,554,111 entitled “Bone Cleaning and Drying system,” U.S. Pat. No. 5,707,974 entitled “Apparatus for Preparing the Medullary Cavity,” U.S. Pat. No. 6,478,751 entitled “Bone Marrow Aspiration Needle,” and U.S. Pat. No. 6,958,252 entitled “Apparatus for Extracting Bone Marrow.”


A guidewire (not shown) may be introduced into the bone 902 via the access hole 910 and placed between bone fragments 904 and 906 of the bone 902 to cross the location of a fracture 905. The guidewire may be delivered into the lumen of the bone 902 and may cross the location of the break 905 so that the guidewire spans multiple sections of bone fragments. As shown in FIG. 9B, the expandable member 200 of the delivery catheter 101 for repairing a fractured bone, which is constructed and arranged to accommodate the guidewire, is delivered over the guidewire to the site of the fracture 905 and spans the bone fragments 904 and 906 of the bone 902. Once the expandable member 200 is in place, the guidewire may be removed. The location of the expandable member 200 may be determined using at least one radiopaque marker 990 which is detectable from the outside or the inside of the bone 902. Once the expandable member 200 is in the correct position within the fractured bone 902, a delivery system which contains a light-sensitive liquid is attached to the port 195. The light-sensitive liquid is then infused through the inner void 210 in the delivery catheter 101 and enters the inner cavity 295 of the expandable member 200. This addition of the light-sensitive liquid within the expandable member 200 causes the expandable member 200 to expand, as shown in FIG. 9C. As the expandable member 200 is expanded, the fracture 905 is reduced. Unlike traditional implants, such as rods, that span the fracture site, the expandable member 200 of the present disclosure does more than provide longitudinal strength to both sides of the fractured bone. In some embodiments, the expandable member 200 having the design can be a spacer for reducing the fracture and for holding the fractured and compressed bones apart at the point of the collapsed fracture.


Once orientation of the bone fragments 904 and 906 are confirmed to be in a desired position, the light-sensitive liquid may be hardened within the expandable member 200, as shown in FIG. 9D, such as by illumination with a visible emitting light source. In some embodiments, during the curing step, a syringe housing a cooling media may be attached to the proximal end of the delivery catheter and continuously delivered to the expandable member 200. The cooling media can be collected by connecting tubing to the distal end of the inner lumen and collecting the cooling media via the second distal access hole. After the light-sensitive liquid has been hardened, the light source may be removed from the device. Alternatively, the light source may remain in the expandable member 200 to provide increased rigidity.



FIG. 9E shows an embodiment of a bone fixation device in a cavity of a bone after being separated from an introducer. For example, the expandable member 200 once hardened, may be released from the delivery catheter 101 to form a photodynamic bone fixation device inside the intramedullary cavity of the bone 902.


In some embodiments, a device for internal bone fixation includes an delivery catheter having a proximal end and a distal end, an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member.


In some embodiments, a device for internal bone fixation includes an delivery catheter having a proximal end and a distal end, a distal cap positioned distally of the delivery catheter, an inner lumen extending through the delivery catheter past the distal end of the delivery catheter for insertion into the distal cap, and an expandable member releasably attached about the distal end of the delivery catheter at its proximal region and is sealed by the distal cap at its distal region.


In some embodiments, a system for internal bone fixation includes an delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light cure adhesive, wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of a light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.


In some embodiments, a method for internal bone fixation that includes advancing to a fractured bone a device that includes an delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member of the device within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.


In some embodiments, a device for bone fixation includes a delivery catheter comprising an outer tube and an inner tube disposed within the outer tube and extending beyond the outer tube; an expandable member having a proximal region and a distal region, the expandable member being relesably attached about a distal end of the delivery catheter at the proximal region of the expandable member, and a distal cap attached to the distal region of the expandable member to seal the expandable member; and an inner compartment in the distal region of the expandable member, the inner compartment being configured to receive the inner tube and enable movement of the inner tube within the inner compartment.


In some embodiments, a system for bone fixation includes a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member; a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light-sensitive liquid; wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.


In some embodiments, a method for bone fixation includes advancing to a fractured bone a device comprising a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is attached about the distal end of the delivery catheter at the proximal region of the expandable member; and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.


All patents, patent applications, and published references cited herein are hereby incorporated by reference in their entirety. It should be emphasized that the above-described embodiments of the present disclosure are merely possible examples of implementations, merely set forth for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiment(s) without departing substantially from the spirit and principles of the disclosure. It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. All such modifications and variations are intended to be included herein within the scope of this disclosure, and as fall within the scope of the appended claims

Claims
  • 1. A device for bone fixation comprising: a delivery catheter comprising an outer tube and an inner tube, the inner tube disposed within the outer tube and the inner tube extending beyond the outer tube;an expandable member having a proximal region and an open distal region, the expandable member being releasably attached about a distal end of the delivery catheter at the proximal region of the expandable member; anda distal cap comprising an outer surface, an inner surface and a body extending from the inner surface, wherein an outer diameter of the body is smaller than a diameter of the inner surface to provide a recessed attachment section, the open distal region of the expandable member being attached to an outside of the body at the recessed attachment section, and wherein the distal cap terminates and seals off the open distal region of the expandable member to prevent the flow of a light-sensitive liquid from inside to outside of the expandable member and the ingress of bodily fluids inside the expandable member; andan inner compartment defined by an inside of the body of the distal cap in the open distal region of the expandable member, wherein the inner compartment is sized so when the inner tube is inserted into the inner compartment, the inner tube is freely moveable within the inner compartment in a radial direction.
  • 2. The device of claim 1 wherein the body of the distal cap is a tubular body defining the inner compartment for receiving and accommodating the inner tube, so as to stabilize and minimize bowing of the inner tube during operation.
  • 3. The device of claim 2 wherein the delivery catheter includes: an inner void between the inner tube and the outer tube and in fluid communication with an inner cavity within the expandable member to deliver the light-sensitive liquid into the inner cavity of the expandable member, andan inner lumen extending along the inner tube for passing a light-conducting fiber into the expandable member to cure the light sensitive liquid inside the inner cavity of the expandable member.
  • 4. The device of claim 3 further comprising a seal formed between the inner lumen and the inner compartment.
  • 5. The device of claim 1 wherein the inner tube is freely moveable within the inner compartment in the radial direction and a longitudinal direction.
  • 6. The device of claim 1 wherein the inner tube includes a plug insertable into the inner compartment of the distal cap.
  • 7. The device of claim 1 wherein the distal cap includes a slotted wall into which the expandable member is inserted.
  • 8. The device of claim 1 wherein an inner surface of the distal cap faces the body of the distal cap and is in communication with the light sensitive liquid inside a cavity of the expandable member, such that the distal cap seals off the open distal region of the expandable member.
  • 9. The device of claim 1 wherein the distal cap is inserted into the open distal region of the expandable member.
  • 10. A system for bone fixation comprising: a delivery catheter having a proximal end and a distal end and an inner tube extending beyond an outer tube;an expandable member having a proximal region and an open distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member;a light-sensitive liquid;a distal cap comprising an outer surface, an inner surface and a body extending from the inner surface, wherein an outer diameter of the body is smaller than a diameter of the inner surface to provide a recessed attachment section, the open distal region of the expandable member being attached to an outside of the body at the recessed attachment section, and wherein the distal cap terminates and seals off the open distal region of the expandable member to prevent the flow of a light-sensitive liquid from inside to outside of the expandable member and the ingress of bodily fluids inside the expandable member;an inner compartment defined by an inside of the body of the distal cap in the open distal region of the expandable member, wherein the inner compartment is sized so when the inner tube is inserted into the inner compartment, the inner tube is freely moveable within the inner compartment in a radial direction; anda light conducting fiber;wherein the delivery catheter has an inner void for passage of the light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.
  • 11. The system of claim 10 wherein the inner tube is free floating within the inner compartment of the distal cap.
  • 12. The system of claim 10 wherein the inner tube includes a plug insertable into the inner compartment of the distal cap.
  • 13. The system of claim 10 wherein the distal cap includes a slotted wall into which the expandable member is inserted.
  • 14. A device for bone repair comprising: a delivery catheter comprising an outer tube and a central tube, the central tube disposed within the outer tube and the central tube extending beyond the outer tube;an expandable member having a proximal region and an open distal region, the proximal region of the expandable member being releasably engaged to a distal end of the delivery catheter; anda distal capcomprising an outer surface, an inner surface and a body extending from the inner surface, wherein an outer diameter of the body is smaller than a diameter of the inner surface to provide a recessed attachment section, the open distal region of the expandable member engaging an outside of the body at the recessed attachment section, and wherein the distal cap that terminates and seals off the open distal region of the expandable member to prevent the flow of a light-sensitive liquid from inside to outside of the expandable member and the ingress of bodily fluids inside the expandable member, wherein at least a portion of the distal cap includes a reflective material; andan inner compartment defined by an inside of the body of the distal cap in the open distal region of the expandable member, wherein the inner compartment is sized so when the inner tube is inserted into the inner compartment, the inner tube is freely moveable within the inner compartment in a radial direction.
  • 15. The device of claim 14 wherein the central tube is tethered to the distal cap by one of a filament or a fiber.
  • 16. The device of claim 14 wherein the distal cap is in communication with the light sensitive liquid inside the expandable member.
RELATED APPLICATIONS

This application claims the benefit of and priority to U.S. Provisional Application No. 61/739,972, which was filed on Dec. 20, 2012, and which is incorporated herein by reference in its entirety.

US Referenced Citations (464)
Number Name Date Kind
3485520 Alexander Dec 1969 A
4271839 Fogarty et al. Jun 1981 A
4280233 Raab Jul 1981 A
4294251 Greenwald et al. Oct 1981 A
4313434 Segal Feb 1982 A
4341691 Anuta Jul 1982 A
4369772 Miller Jan 1983 A
4414608 Furihata Nov 1983 A
4422719 Orcutt Dec 1983 A
4433898 Nasiri Feb 1984 A
4462394 Jacobs Jul 1984 A
4466435 Murray Aug 1984 A
4562598 Kranz Jan 1986 A
4686973 Frisch Aug 1987 A
4697584 Haynes Oct 1987 A
4735625 Davidson Apr 1988 A
4870953 DonMicheal et al. Oct 1989 A
4888024 Powlan Dec 1989 A
4892550 Huebsch Jan 1990 A
4904391 Freeman Feb 1990 A
4961424 Kubota et al. Oct 1990 A
4963151 Ducheyne et al. Oct 1990 A
4969888 Scholten et al. Nov 1990 A
5030093 Mitnick Jul 1991 A
5049157 Mittelmeier et al. Sep 1991 A
5085660 Lin Feb 1992 A
5092899 Forte Mar 1992 A
5102413 Poddar Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5112333 Fixel May 1992 A
5207669 Baker et al. May 1993 A
5222958 Chin Jun 1993 A
5295733 LeBegue Mar 1994 A
5295962 Crocker et al. Mar 1994 A
5303718 Krajicek Apr 1994 A
5316550 Forte May 1994 A
5336699 Cooke et al. Aug 1994 A
5372598 Luhr et al. Dec 1994 A
5376123 Klaue et al. Dec 1994 A
5391144 Sakurai et al. Feb 1995 A
5415654 Daikuzono May 1995 A
5423850 Berger Jun 1995 A
5432876 Appeldorn et al. Jul 1995 A
5443468 Johnson Aug 1995 A
5445608 Chen et al. Aug 1995 A
5462552 Kiester Oct 1995 A
5480400 Berger Jan 1996 A
5538514 Hawkins Jul 1996 A
5548676 Savage, Jr. Aug 1996 A
5554111 Morrey et al. Sep 1996 A
5556429 Felt Sep 1996 A
5571204 Nies Nov 1996 A
5658310 Berger Aug 1997 A
5658963 Qian et al. Aug 1997 A
5705181 Cooper et al. Jan 1998 A
5707374 Schmidt Jan 1998 A
5713901 Tock Feb 1998 A
5795353 Felt Aug 1998 A
5824087 Aspden et al. Oct 1998 A
5827289 Reiley et al. Oct 1998 A
5888220 Felt et al. Mar 1999 A
5897557 Chin et al. Apr 1999 A
5908433 Eager et al. Jun 1999 A
5930424 Heimberger et al. Jul 1999 A
5972015 Scribner et al. Oct 1999 A
5980075 Sheaffer Nov 1999 A
5980253 Oxman et al. Nov 1999 A
5987199 Zarian et al. Nov 1999 A
5989230 Frassica Nov 1999 A
5997570 Ligtenberg et al. Dec 1999 A
6008264 Ostler Dec 1999 A
6019761 Gustilo Feb 2000 A
6019774 Weiss et al. Feb 2000 A
6033411 Preissman Mar 2000 A
6039762 McKay Mar 2000 A
6042380 De Rowe Mar 2000 A
6048346 Reiley et al. Apr 2000 A
6053917 Sherman et al. Apr 2000 A
6059789 Dinger et al. May 2000 A
6066154 Reiley et al. May 2000 A
6077265 Werding et al. Jun 2000 A
6079868 Rydell Jun 2000 A
6103203 Fischer Aug 2000 A
6110176 Shapira Aug 2000 A
6121341 Sawhney et al. Sep 2000 A
6127597 Beyar et al. Oct 2000 A
6136011 Stambaugh Oct 2000 A
6140452 Felt et al. Oct 2000 A
6159236 Biel Dec 2000 A
6179852 Strickland et al. Jan 2001 B1
6195477 Denuto et al. Feb 2001 B1
6200134 Kovac et al. Mar 2001 B1
6217581 Tolson Apr 2001 B1
6223085 Dann et al. Apr 2001 B1
6224630 Bao et al. May 2001 B1
6235043 Reiley May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6248131 Felt et al. Jun 2001 B1
6254571 Hart Jul 2001 B1
6258089 Campbell et al. Jul 2001 B1
6261289 Levy Jul 2001 B1
6280456 Scribner et al. Aug 2001 B1
6282013 Ostler et al. Aug 2001 B1
6290382 Bourn et al. Sep 2001 B1
6299597 Buscemi et al. Oct 2001 B1
6306177 Felt et al. Oct 2001 B1
6319255 Grundei et al. Nov 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6336914 Gillespie, III Jan 2002 B1
6336930 Stalcup et al. Jan 2002 B1
6358252 Shapira Mar 2002 B1
6387098 Cole et al. May 2002 B1
6395007 Bhatnagar et al. May 2002 B1
6416531 Chen Jul 2002 B2
6416737 Manolagas et al. Jul 2002 B1
6419483 Adam et al. Jul 2002 B1
6423055 Farr et al. Jul 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425923 Stalcup et al. Jul 2002 B1
6440444 Boyce et al. Aug 2002 B2
6443988 Felt et al. Sep 2002 B2
6447514 Stalcup et al. Sep 2002 B1
6458375 Gertzman et al. Oct 2002 B1
6478751 Krueger et al. Nov 2002 B1
6482234 Weber et al. Nov 2002 B1
6485512 Cheng Nov 2002 B1
6494883 Ferree Dec 2002 B1
6524251 Rabiner et al. Feb 2003 B2
6524313 Fassier et al. Feb 2003 B1
6551321 Burkinshaw et al. Apr 2003 B1
6551337 Rabiner et al. Apr 2003 B1
6565528 Mueller May 2003 B1
6579277 Rabiner et al. Jun 2003 B1
6579279 Rabiner et al. Jun 2003 B1
6605056 Eidenschink et al. Aug 2003 B2
6620185 Harvie et al. Sep 2003 B1
6623505 Scribner et al. Sep 2003 B2
6632235 Weikel et al. Oct 2003 B2
6648881 KenKnight et al. Nov 2003 B2
6652547 Rabiner et al. Nov 2003 B2
6652587 Felt et al. Nov 2003 B2
6660013 Rabiner et al. Dec 2003 B2
6679873 Rabiner et al. Jan 2004 B2
6695781 Rabiner et al. Feb 2004 B2
6695782 Rabiner et al. Feb 2004 B2
6696073 Boyce et al. Feb 2004 B2
6716216 Boucher et al. Apr 2004 B1
6719773 Boucher et al. Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6730048 Hare et al. May 2004 B1
6733451 Rabiner et al. May 2004 B2
6733513 Boyle et al. May 2004 B2
6740093 Hochschuler et al. May 2004 B2
6755862 Keynan Jun 2004 B2
6783530 Levy Aug 2004 B1
6802835 Rabiner et al. Oct 2004 B2
6818018 Sawhney Nov 2004 B1
6852095 Ray Feb 2005 B1
6866678 Shenderova et al. Mar 2005 B2
6869442 Cheng Mar 2005 B2
6875212 Shaolian et al. Apr 2005 B2
6885246 Tsutsui et al. Apr 2005 B2
6887246 Bhatnagar et al. May 2005 B2
6887275 Carchidi et al. May 2005 B2
6899713 Shaolian et al. May 2005 B2
6899719 Reiley et al. May 2005 B2
6932843 Smith et al. Aug 2005 B2
6964667 Shaolian et al. Nov 2005 B2
6975898 Seibel Dec 2005 B2
6979341 Scribner et al. Dec 2005 B2
6981981 Reiley et al. Jan 2006 B2
7001431 Bao et al. Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7048731 Altshuler May 2006 B2
7052498 Levy et al. May 2006 B2
7077865 Bao et al. Jul 2006 B2
7124067 Ascenzi Oct 2006 B2
7141061 Williams et al. Nov 2006 B2
7144414 Harvie et al. Dec 2006 B2
7153305 Johnson et al. Dec 2006 B2
7156861 Scribner et al. Jan 2007 B2
7156880 Evans et al. Jan 2007 B2
7169140 Kume Jan 2007 B1
7215863 Arenella et al. May 2007 B1
7241303 Reiss et al. Jul 2007 B2
7252677 Burwell et al. Aug 2007 B2
7258692 Thelen et al. Aug 2007 B2
7261720 Stevens et al. Aug 2007 B2
7320709 Felt et al. Jan 2008 B2
7341601 Eisermann et al. Mar 2008 B2
7360542 Nelson et al. Apr 2008 B2
7407616 Melikechi et al. Aug 2008 B2
7419450 Ito Sep 2008 B2
7427295 Ellman et al. Sep 2008 B2
7465318 Sennett et al. Dec 2008 B2
7547319 Segal et al. Jun 2009 B2
7621950 Globerman et al. Nov 2009 B1
7628800 Sherman et al. Dec 2009 B2
7632277 Woll et al. Dec 2009 B2
7632291 Stephens et al. Dec 2009 B2
7666205 Weikel et al. Feb 2010 B2
7722620 Truckai et al. May 2010 B2
7740656 Mensah et al. Jun 2010 B2
7744555 DiMauro et al. Jun 2010 B2
7766965 Bao et al. Aug 2010 B2
7771476 Justis et al. Aug 2010 B2
7776075 Bruneau et al. Aug 2010 B2
7806900 Rabiner Oct 2010 B2
7811284 Rabiner et al. Oct 2010 B2
7811286 Medoff Oct 2010 B2
7811290 Rabiner Oct 2010 B2
7842040 Rabiner et al. Nov 2010 B2
7850711 Stone et al. Dec 2010 B1
7857748 Williams et al. Dec 2010 B2
7879041 Rabiner Feb 2011 B2
7912539 Doty et al. Mar 2011 B2
7947015 Herweck et al. May 2011 B2
8034071 Scribner et al. Oct 2011 B2
8123807 Kim et al. Feb 2012 B2
8187278 Biel May 2012 B2
8210729 O'Leary et al. Jul 2012 B2
8211121 Quinn et al. Jul 2012 B1
8246628 Rabiner Aug 2012 B2
8262694 Widomski et al. Sep 2012 B2
8328402 O'Leary et al. Dec 2012 B2
8348956 Rabiner Jan 2013 B2
8366711 Rabiner et al. Feb 2013 B2
8403968 Rabiner et al. Mar 2013 B2
8413664 Appling Apr 2013 B2
8512338 Rabiner et al. Aug 2013 B2
8545499 Lozier et al. Oct 2013 B2
8574233 Rabiner et al. Nov 2013 B2
8668701 Rabiner Mar 2014 B2
8672982 Rabiner et al. Mar 2014 B2
8684965 Rabiner et al. Apr 2014 B2
8708955 Tilson et al. Apr 2014 B2
8734460 Rabiner et al. May 2014 B2
8764761 Truckai et al. Jul 2014 B2
8870965 Rabiner et al. Oct 2014 B2
8906030 Rabiner et al. Dec 2014 B2
8906031 Rabiner et al. Dec 2014 B2
8915966 Rabiner et al. Dec 2014 B2
8936382 O'Leary et al. Jan 2015 B2
8936644 Rabiner et al. Jan 2015 B2
8939977 DiPoto et al. Jan 2015 B2
9005254 Rabiner et al. Apr 2015 B2
9050079 Rabiner et al. Jun 2015 B2
9101419 Colleran et al. Aug 2015 B2
9125706 Rabiner et al. Sep 2015 B2
9144442 Rabiner et al. Sep 2015 B2
9179959 Rabiner et al. Nov 2015 B2
9216049 Rabiner et al. Dec 2015 B2
9254156 Rabiner Feb 2016 B2
9254195 Rabiner et al. Feb 2016 B2
9265549 Rabiner Feb 2016 B2
9427289 Rabiner et al. Aug 2016 B2
9433450 Rabiner et al. Sep 2016 B2
20010011174 Reiley et al. Aug 2001 A1
20010044626 Reiley et al. Nov 2001 A1
20010055462 Seibel Dec 2001 A1
20020032444 Mische Mar 2002 A1
20020082600 Shaolian et al. Jun 2002 A1
20020091424 Biel Jul 2002 A1
20020156482 Scribner et al. Oct 2002 A1
20020161373 Osorio et al. Oct 2002 A1
20020165544 Perren et al. Nov 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030028210 Boyle et al. Feb 2003 A1
20030083642 Boyd et al. May 2003 A1
20030105469 Karmon Jun 2003 A1
20030114914 Cheng Jun 2003 A1
20030156431 Gozum et al. Aug 2003 A1
20030199850 Chavez et al. Oct 2003 A1
20030212426 Olson et al. Nov 2003 A1
20030229372 Reiley et al. Dec 2003 A1
20040006341 Shaolian et al. Jan 2004 A1
20040024388 Altshuler Feb 2004 A1
20040034434 Evans et al. Feb 2004 A1
20040059333 Carl et al. Mar 2004 A1
20040059417 Smith et al. Mar 2004 A1
20040092948 Stevens et al. May 2004 A1
20040098015 Weikel et al. May 2004 A1
20040117025 Reindel Jun 2004 A1
20040133280 Trieu Jul 2004 A1
20040167561 Boucher et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040225296 Reiss et al. Nov 2004 A1
20040228142 Takada et al. Nov 2004 A1
20040230309 DiMauro et al. Nov 2004 A1
20040236366 Kennedy, II Nov 2004 A1
20040247641 Felt et al. Dec 2004 A1
20050010231 Myers Jan 2005 A1
20050010297 Watson et al. Jan 2005 A1
20050015140 deBeer Jan 2005 A1
20050015148 Jansen et al. Jan 2005 A1
20050018989 Shimizu et al. Jan 2005 A1
20050033437 Bao et al. Feb 2005 A1
20050043733 Eisermann et al. Feb 2005 A1
20050043808 Felt et al. Feb 2005 A1
20050049691 Mericle et al. Mar 2005 A1
20050090901 Studer Apr 2005 A1
20050119662 Reiley et al. Jun 2005 A1
20050142315 DeSimone et al. Jun 2005 A1
20050149022 Shaolian et al. Jul 2005 A1
20050159749 Levy et al. Jul 2005 A1
20050171604 Michalow Aug 2005 A1
20050192671 Bao et al. Sep 2005 A1
20050197711 Cachia Sep 2005 A1
20050228260 Burwell et al. Oct 2005 A1
20050234453 Shaolian et al. Oct 2005 A1
20050251140 Shaolian et al. Nov 2005 A1
20050284485 Nelson et al. Dec 2005 A9
20060009550 Messersmith et al. Jan 2006 A1
20060015105 Warren et al. Jan 2006 A1
20060036253 Leroux et al. Feb 2006 A1
20060084985 Kim et al. Apr 2006 A1
20060100547 Rabiner et al. May 2006 A1
20060100635 Reiley et al. May 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060111726 Felt et al. May 2006 A1
20060122625 Truckai et al. Jun 2006 A1
20060142747 Appling Jun 2006 A1
20060155296 Richter Jul 2006 A1
20060173464 Ellman et al. Aug 2006 A1
20060183811 Melikechi et al. Aug 2006 A1
20060184246 Zwirkoski Aug 2006 A1
20060195165 Gertner et al. Aug 2006 A1
20060217747 Ferree Sep 2006 A1
20060229617 Meller et al. Oct 2006 A1
20060229625 Truckai et al. Oct 2006 A1
20060247787 Rydell et al. Nov 2006 A1
20060253102 Nance et al. Nov 2006 A1
20060253200 Bao et al. Nov 2006 A1
20060258981 Eidenschink Nov 2006 A1
20060264950 Nelson et al. Nov 2006 A1
20060264951 Nelson et al. Nov 2006 A1
20060264952 Nelson et al. Nov 2006 A1
20060265077 Zwirkoski Nov 2006 A1
20060271024 Gertner et al. Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060276793 Berry Dec 2006 A1
20060276819 Osorio et al. Dec 2006 A1
20060282169 Felt et al. Dec 2006 A1
20060287730 Segal et al. Dec 2006 A1
20070027547 Rydell et al. Feb 2007 A1
20070067032 Felt et al. Mar 2007 A1
20070087031 Ashman et al. Apr 2007 A1
20070100327 Smith May 2007 A1
20070104416 Shimizu et al. May 2007 A1
20070118143 Ralph et al. May 2007 A1
20070123876 Czartoski et al. May 2007 A1
20070123877 Goldin et al. May 2007 A1
20070123878 Shaver et al. May 2007 A1
20070161991 Altarac et al. Jul 2007 A1
20070198023 Sand et al. Aug 2007 A1
20070225705 Osario et al. Sep 2007 A1
20070233146 Henniges et al. Oct 2007 A1
20070239148 Scheller Oct 2007 A1
20070255287 Rabiner Nov 2007 A1
20080015500 Herweck et al. Jan 2008 A1
20080019657 Maitland et al. Jan 2008 A1
20080021474 Bonutti et al. Jan 2008 A1
20080039854 Rabiner Feb 2008 A1
20080080205 Forrester et al. Apr 2008 A1
20080103505 Fransen May 2008 A1
20080125784 Rabiner et al. May 2008 A1
20080154266 Protopsaltis et al. Jun 2008 A1
20080154368 Justis Jun 2008 A1
20080154373 Protopsaltis et al. Jun 2008 A1
20080183122 Fisher et al. Jul 2008 A1
20080188805 Davies et al. Aug 2008 A1
20080188858 Luzzi et al. Aug 2008 A1
20080234820 Felt et al. Sep 2008 A1
20080249529 Zarda et al. Oct 2008 A1
20080255560 Myers et al. Oct 2008 A1
20080269750 Justin Oct 2008 A1
20080287951 Stoneburger et al. Nov 2008 A1
20080308753 Stuba et al. Dec 2008 A1
20090005782 Chirico et al. Jan 2009 A1
20090018524 Greenhalgh et al. Jan 2009 A1
20090024166 Carl et al. Jan 2009 A1
20090048629 Rabiner Feb 2009 A1
20090054900 Rabiner et al. Feb 2009 A1
20090076610 Afzal et al. Mar 2009 A1
20090093887 Walter et al. Apr 2009 A1
20090112196 Rabiner et al. Apr 2009 A1
20090118833 Hudgins et al. May 2009 A1
20090125028 Teisen et al. May 2009 A1
20090171265 Doty et al. Jul 2009 A1
20090171358 Chang et al. Jul 2009 A1
20090177204 Colleran et al. Jul 2009 A1
20090182336 Brenzel et al. Jul 2009 A1
20090187192 Rabiner et al. Jul 2009 A1
20090216232 Buford, III et al. Aug 2009 A1
20090228007 Justin et al. Sep 2009 A1
20090254064 Boatman Oct 2009 A1
20090287309 Walch et al. Nov 2009 A1
20090306589 Tilson et al. Dec 2009 A1
20100076503 Beyar et al. Mar 2010 A1
20100234958 Linares Sep 2010 A1
20100241178 Tilson et al. Sep 2010 A1
20100249942 Goswami et al. Sep 2010 A1
20100256641 Rabiner et al. Oct 2010 A1
20100262069 Rabiner et al. Oct 2010 A1
20100262188 Rabiner et al. Oct 2010 A1
20100265733 O'Leary et al. Oct 2010 A1
20100318087 Scribner et al. Dec 2010 A1
20100331850 Rabiner Dec 2010 A1
20110004213 Rabiner et al. Jan 2011 A1
20110009871 Rabiner Jan 2011 A1
20110029093 Bojarski et al. Feb 2011 A1
20110046746 Rabiner et al. Feb 2011 A1
20110077651 Lozier et al. Mar 2011 A1
20110082504 Singhatt et al. Apr 2011 A1
20110098713 Rabiner et al. Apr 2011 A1
20110110114 Papac et al. May 2011 A1
20110112588 Linderman et al. May 2011 A1
20110118740 Rabiner et al. May 2011 A1
20110137317 O'Halloran et al. Jun 2011 A1
20110160870 Baumgartner et al. Jun 2011 A1
20110166306 Stansbury et al. Jul 2011 A1
20110218626 Krinke et al. Sep 2011 A1
20110268866 Parker Nov 2011 A1
20110288522 Hollowel et al. Nov 2011 A1
20110313356 Rabiner et al. Dec 2011 A1
20120016371 O'Halloran et al. Jan 2012 A1
20120022540 Chasmawala et al. Jan 2012 A1
20120029102 Rose et al. Feb 2012 A1
20120041557 Frigg Feb 2012 A1
20120165941 Rabiner et al. Jun 2012 A1
20120259375 Druma et al. Oct 2012 A1
20120262939 O'Leary et al. Oct 2012 A1
20120289968 Rabiner Nov 2012 A1
20120316652 Renganath et al. Dec 2012 A1
20130003406 O'Leary et al. Jan 2013 A1
20130006304 Rabiner et al. Jan 2013 A1
20130012998 Altarac et al. Jan 2013 A1
20130013008 Rabiner et al. Jan 2013 A1
20130013009 Colleran et al. Jan 2013 A1
20130013010 Rabiner et al. Jan 2013 A1
20130018482 Meridew et al. Jan 2013 A1
20130023876 Rabiner et al. Jan 2013 A1
20130023877 Rabiner et al. Jan 2013 A1
20130023886 Rabiner et al. Jan 2013 A1
20130041472 Rabiner et al. Feb 2013 A1
20130046390 Rabiner et al. Feb 2013 A1
20130066326 Rabiner et al. Mar 2013 A1
20130158607 Rabiner et al. Jun 2013 A1
20130184715 Rabiner et al. Jul 2013 A1
20130310875 Rabiner et al. Nov 2013 A1
20140018806 DiPoto et al. Jan 2014 A1
20140135847 Rabiner et al. May 2014 A1
20140142581 Rabiner May 2014 A1
20140148813 Rabiner May 2014 A1
20140163453 Rabiner et al. Jun 2014 A1
20150066028 Rabiner et al. Mar 2015 A1
20150066085 Rabiner et al. Mar 2015 A1
20150080900 Rabiner et al. Mar 2015 A1
20150088268 Rabiner et al. Mar 2015 A1
20150374498 Rabiner et al. Dec 2015 A1
20160022333 Rabiner et al. Jan 2016 A1
20160128750 Rabiner et al. May 2016 A1
20160128836 Rabiner et al. May 2016 A1
Foreign Referenced Citations (51)
Number Date Country
40 28 466 Mar 1992 DE
0 709 698 May 1996 EP
2 298 201 Mar 2011 EP
2001-527437 Dec 2001 JP
2004-526525 Sep 2002 JP
2005-511143 Apr 2005 JP
2006-212425 Aug 2006 JP
9001858 Mar 1992 NL
WO 9838918 Sep 1998 WO
WO9943266 Sep 1999 WO
0230338 Apr 2002 WO
WO 0243628 Jun 2002 WO
WO 03047472 Jun 2003 WO
WO 2004045393 Jun 2004 WO
WO 2004058045 Jul 2004 WO
WO 2004073563 Sep 2004 WO
WO 2004112661 Dec 2004 WO
2005102224 Nov 2005 WO
WO 2005112804 Dec 2005 WO
WO 2006016807 Feb 2006 WO
WO2007002251 Jan 2007 WO
WO 2007059259 May 2007 WO
WO 2007075375 Jul 2007 WO
WO 2007127255 Nov 2007 WO
WO 2007127260 Nov 2007 WO
2008021972 Feb 2008 WO
WO 2008039811 Apr 2008 WO
WO 2008063265 May 2008 WO
2008096363 Aug 2008 WO
WO 2009059090 May 2009 WO
WO 2009064847 May 2009 WO
2009091811 Jul 2009 WO
WO 2009082688 Jul 2009 WO
WO2009088927 Jul 2009 WO
WO 2009131999 Oct 2009 WO
WO 2010050965 May 2010 WO
WO 2010118158 Oct 2010 WO
WO 2011060062 May 2011 WO
2011006652 Jun 2011 WO
WO 2011071567 Jun 2011 WO
WO 2011162910 Dec 2011 WO
WO2011162910 Dec 2011 WO
2012050583 Apr 2012 WO
WO2012051312 Apr 2012 WO
WO 2012088432 Jun 2012 WO
WO 2013013069 Jan 2013 WO
WO 2013013071 Jan 2013 WO
WO 2013013072 Jan 2013 WO
WO2013059609 Apr 2013 WO
WO2014011669 Jan 2014 WO
WO 2014100427 Jun 2014 WO
Non-Patent Literature Citations (113)
Entry
Jovanovic et al., “Fixion Nails for Humeral Fractures, Injury”, Int. J. Care Injured, vol. 35, Issue 11, pp. 1140-1142, Nov. 2004.
Maruyama et al., “Metacarpal Fracture Fixation with Absorbable Polyglycolide Rods and Stainless Steel K Wires: A Biomechanical Comparison”, Journal of Biomedical Materials Research (Applied Biomaterials), vol. 33, Issue 1, pp. 9-12, Apr. 1996.
Waris et al., “Bioabsorbable Miniplating Versus Metallic Fixation for Metacarpal Fractures”, Clinical Orthopaedics and Related Research, No. 410, pp. 310-319, May 2003.
Waris et al., “Self-Reinforced Bioabsorbable Versus Metallic Fixation Systems for Metacarpal and Phalangeal Fractures: A Biomechanical Study”, The Journal of Hand Surgery, vol. 27A, No. 5, pp. 902-909, Sep. 2002.
PCT International Search Report based on PCT/US07/20402 dated Apr. 1, 2008.
PCT International Search Report based on PCT/US07/10050 dated Apr. 17, 2008.
PCT International Search Report based on PCT/US07/10038 dated Aug. 27, 2008.
PCT International Search Report based on PCT/US08/81929 dated Jan. 12, 2009.
PCT International Search Report based on PCT/US08/81924 dated Feb. 9, 2009.
PCT International Search Report based on PCT/US08/87630 dated Feb. 24, 2009.
PCT International Search Report based on PCT/US10/30275 dated Aug. 11, 2010.
PCT International Search Report based on PCT/US10/56219 dated Jan. 20, 2011.
PCT International Search Report based on PCT/US10/46003 dated May 24, 2011.
PCT International Search Report based on PCT/US11/38389 dated Sep. 22, 2011.
PCT International Search Report based on PCT/US11/66871 dated May 1, 2012.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 29, 2009.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Mar. 11, 2010.
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 30, 2010.
USPTO Office Action in U.S. Appl. No. 11/789,907 mailed May 11, 2010.
USPTO Office Action in U.S. Appl. No. 11/903,123 mailed Jul. 1, 2010.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Dec. 9, 2010.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Apr. 28, 2011.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Sep. 23, 2011.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Mar. 16, 2012.
USPTO Office Action in U.S. Appl. No. 12/262,411 mailed Sep. 1, 2010.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Dec. 23, 2011.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed May 11, 2012.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Oct. 24, 2011.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Apr. 4, 2012.
USPTO Office Action in U.S. Appl. No. 12/875,460 mailed Mar. 8, 2012.
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Dec. 27, 2011.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed May 29, 2012.
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Jun. 8, 2012.
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Jun. 26, 2012.
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Jul. 6, 2012.
Extended European Search Report based on EP 07 75 6022 dated Jul. 30, 2012.
Extended European Search Report based on EP 07 75 6016 dated Jul. 30, 2012.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Aug. 1, 2012.
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Aug. 2, 2012.
USPTO Office Action inU.S. Appl. No. 12/886,288 mailed Aug. 15, 2012.
PCT International Search Report based on PCT/US12/47447 dated Oct. 2, 2012.
PCT International Search Report based on PCT/US12/47446 dated Oct. 15, 2012.
PCT International Search Report based on PCT/US12/47444 dated Oct. 18, 2012.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 25, 2012.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Nov. 9, 2012.
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Dec. 3, 2012.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jan. 17, 2013.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Dec. 14, 2012.
International Search Report and Written Opinion for PCT/US2012/061047 mailed Jan. 7, 2013.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Jan. 22, 2013.
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Jan. 23, 2013.
Supplemental European Search Report based on EP 08 87 7881 dated May 15, 2013.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Feb. 4, 2013.
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Mar. 13, 2013.
USPTO Office Action in U.S. Appl. No. 13/616,416 mailed Mar. 25, 2013.
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Apr. 23, 2013.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Apr. 26, 2013.
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed May 13, 2013.
USPTO Office Action in U.S. Appl. No. 13/772,947 mailed Jun. 19, 2013.
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jul. 9, 2013.
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Sep. 16, 2013.
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Sep. 17, 2013.
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Sep. 25, 2013.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Oct. 9, 2013.
Extended European Search Report based on EP 10 76 2390 dated Oct. 30, 2013.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Nov. 21, 2013.
USPTO Office Action in U.S. Appl. No. 12/983,496 mailed Feb. 5, 2014.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Feb. 13, 2014.
USPTO Office Action in U.S. Appl. No. 13/617,181 mailed Feb. 25, 2014.
PCT International Search Report based on PCT/US13/076598 dated Mar. 19, 2014.
USPTO Office Action in U.S. Appl. No. 13/655,808 mailed Mar. 27, 2014.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed May 7, 2014.
Extended European Search Report based on EP 14156473 dated May 13, 2014.
USPTO Office Action in U.S. Appl. No. 13/800,518 mailed Jun. 10, 2014.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jun. 26, 2014.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jun. 27, 2014.
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Jul. 31, 2014.
USPTO Office Action in U.S. Appl. No. 13/616,781 mailed Aug. 26, 2014.
USPTO Office Action in U.S. Appl. No. 13/730,521 mailed Sep. 8, 2014.
PCT International Search Report based on PCT/US13/049773 dated Oct. 1, 2013.
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 7, 2014.
USPTO Office Action in U.S. Appl. No. 13/553,450 mailed Oct. 24, 2014.
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Oct. 24, 2014.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Dec. 5, 2014.
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Dec. 23, 2014.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jan. 14, 2015.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jan. 15, 2015.
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Feb. 9, 2015.
USPTO Office Action in U.S. Appl. No. 13/796,085 mailed Feb. 12, 2015.
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Mar. 31, 2015.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed May 1, 2015.
USPTO Office Action in U.S. Appl. No. 13/297,097 mailed May 29, 2015.
USPTO Office Action in U.S. Appl. No. 14/171,036 mailed Jun. 1, 2015.
USPTO Office Action in U.S. Appl. No. 14/164,846 mailed Jun. 4, 2015.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jul. 15, 2015.
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Jan. 6, 2016.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Mar. 2, 2016.
USPTO Office Action in U.S. Appl. No. 14/535,971 mailed Mar. 4, 2016.
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Sep. 11, 2015.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Sep. 23, 2015.
USPTO Office Action in U.S. Appl. No. 14/164,846 mailed Oct. 14, 2015.
USPTO Office Action in U.S. Appl. No. 14/171,036 mailed Oct. 15, 2015.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Oct. 22, 2015.
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jan. 14, 2016.
USPTO Office Action in U.S. Appl. No. 14/177,748 mailed Jan. 25, 2016.
USPTO Office Action in U.S. Appl. No. 14/535,913 mailed Feb. 22, 2016.
U.S. Appl. No. 14/988,058, filed Jan. 5, 2016, Systems and Methods for Joint Stabilization.
U.S. Appl. No. 14/996,275, filed Jan. 15, 2016, Apparatus for Delivery of Reinforcing Materials to Bone.
USPTO Office Action in U.S. Appl. No. 14/535,913 mailed Sep. 26, 2016.
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Oct. 13, 2016.
USPTO Office Action in U.S. Appl. No. 14/996,275 mailed Nov. 14, 2016.
International Search Report in PCT/US2016/60603 mailed Jan. 30, 2017.
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jun. 2, 2016.
Related Publications (1)
Number Date Country
20140180288 A1 Jun 2014 US
Provisional Applications (1)
Number Date Country
61739972 Dec 2012 US